Redcare Pharmacy N.V.

Redcare Pharmacy N.V.

79.30
EUR
+1.35
(+1.73%)
-2.16EPS
1.34BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.1
9.34
13.85
19.56
29.9
44.8
53.66
67.32
59.29
66.96
93.5
118.21
146.25
159.36
Basic EPS, GAAP
-0.31
-0.56
-1.16
-2.03
-2.25
-2.79
-2.78
-1.17
-4.15
-4.32
-0.63
-2.27
-1.87
-2.08
Free Cash Flow per Basic Share
-0.97
-0.66
-1.41
-2.33
-3.46
-2.19
-3.48
-2.47
-1.76
-4.59
1.21
-1
-4.36
-5.46
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.99
2.21
0.27
10.28
19.88
17.72
17.29
23.7
22.96
19.49
26.26
24.07
22.83
22.66
Tangible Book Value per Share
0.71
0.85
-1.23
7.84
4.34
1.17
2.44
12.29
8.73
3.61
4.73
3.62
3.27
3.46
Basic Weighted Avg Shares
9
9
9
9
9
12
13
14
18
18
19
20
20
20
Sales/Revenue/Turnover
55
85
126
177
284
540
701
968
1,060
1,204
1,799
2,371
2,941
3,217
Operating Margin (%)
-4.61
-5.88
-8.07
-7.8
-7.82
-5.36
-4.88
-0.1
-6.21
-5.76
-0.96
-1.65
-1.01
-0.34
Depreciation Expense
1
2
2
3
7
13
15
16
27
40
57
68
69
69
Net Income, GAAP
-3
-5
-11
-18
-21
-34
-36
-17
-74
-78
-12
-45
-38
-42
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-5.12
-5.95
-8.4
-10.4
-7.52
-6.23
-5.17
-1.73
-7
-6.45
-0.67
-1.92
-1.28
-1.31
Working Capital
5
6
11
75
54
83
151
179
309
225
276
250
219
203
LT Debt
- -
- -
19
- -
4
72
132
33
230
248
236
237
329
331
Total Equity
18
20
2
93
239
214
233
425
415
355
552
510
479
475
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-26.41
-93.7
-38.55
-12.86
-14.84
-16.24
-5.1
-17.65
-20.17
-2.75
-9.04
-7.99
-8.7

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
86
23
24
LT Borrowings
262
- -
- -
LT Finance Leases
67
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
1,320
753
1,344

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
619
579
550
Cash, Cash Equivalents & STI
203
135
119
Accounts Receivable, Net
130
156
153
Inventories
214
215
213
Total Current Liabilities
400
375
347
Payables & Accruals
- -
- -
- -
ST Debt
86
23
24
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
395.43%
5.02%
-6.04%
Free Cash Flow
32.57%
34.93%
338%
Net Income, GAAP
62.54%
104.65%
-17.14%
Sales/Revenue/Turnover
38.77%
25.66%
24.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
560
561
575
675
2,371
2025
717
709
719
795
2,941
2026
850
854
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.39
-0.21
-0.35
-1.32
-2.27
2025
-0.54
0.46
-0.36
-1.44
-1.87
2026
-0.52
0.23
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Peter Franz Schmid
Full Time Employees
2,649
Sector
Distribution services
Industry
Medical distributors
Address
Erik de Rodeweg 11–13 Sevenum LI Netherlands 5975 WD
IPO Date
Oct 13, 2016
Business
Redcare Pharmacy N.V. operates as a leading European online pharmacy, offering a comprehensive portfolio of prescription and over-the-counter medications, nutritional supplements, beauty and personal care products, and pharmacy-related items through its digital platforms and webshops. The company serves customers in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France, with local brands including shop-apotheke.com, farmaline.nl/be, Redcare.it, Redcare-apotheke.ch, Redcare-pharmacie.fr, and others such as smartpatient.eu for medication management, medapp.nl for chronic disease support, and gopuls.de for instant delivery; it also provides digital health services like e-prescription redemption via its CardLink solution and marketplace offerings. Founded in 2001 and headquartered in Sevenum, Netherlands, with distribution centers in Sevenum, Milan, and planned expansion to Pilsen, Redcare Pharmacy rebranded from Shop Apotheke Europe N.V. in June 2023 and completed a strategic partnership with Galenica in spring 2023 to establish Mediservice.ch as the leading online pharmacy in Switzerland, where Galenica increased its stake to over 10% in 2024; recent developments include the launch and gematik extension of the eHealth-CardLink solution in 2025, strong acceleration of Rx sales in Germany reaching 142% growth in Q4 2024, confirmation of full-year guidance after positive Q3 2025 performance, and a Managing Board change with CFO Jasper Eenhorst stepping down in September 2025.

Company News

  • Redcare Pharmacy (OTCMKTS:SAEYY) Stock Price Down 14.4% – Should You Sell?

  • Redcare Pharmacy NV (SAEYY) Q3 2024 Earnings Call Transcript